CGEMCullinan Therapeutics, Inc.
$15.53+150% 1Y
$15.53
$5.7552 weeks$22.98
The financials
Cullinan Therapeutics, Inc. by the numbers
The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$57M | −$76M | n/a |
| Net income | −$54M | −$70M | n/a |
On our screens:Most shorted stocks